Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Enhanced stem cells can reduce fat buildup in eye tissue for Graves' disease.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

Hedgehog pathway inhibitors could be effective in treating melanoma.

Gasdermin A3 overexpression in skin causes inflammation and hair loss.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

CNGA3, GLUD1, and SIRT1 are promising targets for treating aging and glioblastoma.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

PDE3 inhibitor may help treat hair loss by promoting hair growth.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

THSG from a Chinese plant helps with aging and related diseases.

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

SH-340 may improve skin barrier and help treat atopic dermatitis.

Sonidegib and vismodegib have different side effects and reporting patterns.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.